Common Contracts

8 similar Employment Agreement contracts by Sesen Bio, Inc., Eleven Biotherapeutics, Inc.

AutoNDA by SimpleDocs
July 26, 2019
Employment Agreement • November 12th, 2019 • Sesen Bio, Inc. • Pharmaceutical preparations

It is my pleasure to offer you the position of General Counsel & Secretary at Sesen Bio (the “Company" or "Sesen Bio"). Your start date will be August 1, 2019 (the “Commencement Date”). This letter summarizes important details about your employment, should you accept this offer (“Letter Agreement”). This Letter Agreement shall be effective on August 1, 2019, which shall also be your start date (“Effective Date”).

August 26, 2019 Monica Forbes
Employment Agreement • August 26th, 2019 • Sesen Bio, Inc. • Pharmaceutical preparations

It is my pleasure to offer you the position of Chief Financial Officer (“CFO”) at Sesen Bio (the “Company" or "Sesen Bio"). Your commencement date as the CFO will be August 26, 2019 (the “Promotion Date”). This letter summarizes important details about your employment, should you accept this offer (“Letter Agreement”). This Letter Agreement shall be effective on August 26, 2019, which shall also be your start date (the “Effective Date”)

Personal & Confidential
Employment Agreement • December 4th, 2018 • Sesen Bio, Inc. • Pharmaceutical preparations • Pennsylvania
Personal & Confidential
Employment Agreement • August 13th, 2018 • Sesen Bio, Inc. • Pharmaceutical preparations

It is my pleasure to offer you the position of President and Chief Executive Officer for Sesen Bio, Inc. (“the Company” or “Sesen Bio”) reporting to the Board of Directors (the “Board”). This letter summarizes important details about your employment, should you accept this offer. This letter agreement shall be effective on the date hereof.

January 23, 2018 Personal & Confidential Richard Fitzgerald Dear Richard:
Employment Agreement • January 25th, 2018 • Eleven Biotherapeutics, Inc. • Pharmaceutical preparations

It is my pleasure to offer you the position of Chief Financial Officer for Eleven Biotherapeutics, Inc. (the “Company” or “Eleven Bio”) reporting to Stephen Hurly, President and CEO. This letter agreement summarizes important details about your employment, should you accept this offer. This letter agreement shall be effective as of the last date of execution by the parties hereto (the “Effective Date”).

September 20, 2016 Personal & Confidential Stephen Hurly Haddonfield, NJ 08033 Dear Stephen:
Employment Agreement • September 21st, 2016 • Eleven Biotherapeutics, Inc. • Pharmaceutical preparations

It is my pleasure to offer you the position of President and Chief Executive Officer for Eleven Biotherapeutics, Inc. (“the Company” or “Eleven Bio”) reporting to the Board of Directors (the “Board”). This letter summarizes important details about your employment, should you accept this offer. This letter agreement shall be effective only upon the date of the closing (such closing date, the “Effective Date”) of the acquisition by the Company of Viventia Bio Inc. (“Viventia”) pursuant to a Share Purchase Agreement (the “Agreement”), by and among the Company, Viventia, the shareholders of Viventia named on the signature pages thereto and, for certain limited purposes, Clairmark Investments Ltd, pursuant to which Agreement, the Company will acquire all of the outstanding equity interests in Viventia and Viventia will become a wholly-owned subsidiary of the Company (the “Transaction”). If the Transaction does not occur by September 23, 2016, this letter agreement shall be null and void.

September 20, 2016 Personal & Confidential Arthur P. DeCillis, M.D. Madison, CT 06443 Dear Arthur:
Employment Agreement • September 21st, 2016 • Eleven Biotherapeutics, Inc. • Pharmaceutical preparations

It is my pleasure to offer you the position of Chief Medical Officer for Eleven Biotherapeutics, Inc. (“the Company” or “Eleven Bio”) reporting to Stephen Hurly, President and CEO. This letter agreement summarizes important details about your employment, should you accept this offer. This letter agreement shall be effective only upon the date of the closing (such closing date, the “Effective Date”) of the acquisition by the Company of Viventia Bio Inc. (“Viventia”) pursuant to a Share Purchase Agreement (the “Agreement”), by and among the Company, Viventia, the shareholders of Viventia named on the signature pages thereto and, for certain limited purposes, Clairmark Investments Ltd, pursuant to which Agreement, the Company will acquire all of the outstanding equity interests in Viventia and Viventia will become a wholly-owned subsidiary of the Company (the “Transaction”). If the Transaction does not occur by September 23, 2016, this letter agreement shall be null and void.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!